BOSTON--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it was granted the American Podiatric Medical Association (APMA) Seal of Approval for its Quell Wearable Pain Relief device.

'The APMA Seal of Approval is awarded after a rigorous scientific review by a group of APMA member podiatrists. The committee examines information about the product's safety, quality control, and other data,' said APMA Executive Director Dr. Jim Christina. 'Quell received the APMA Seal of Approval which is granted to products found to be effective and promote good foot health.'

Quell is an easy-to-use, over-the-counter device for chronic pain relief. The wearable device utilizes NeuroMetrix's wearable intensive nerve stimulation (WINS) technology to provide pain relief. In a recent clinical study, 81 percent of participants reported improvement with chronic pain and overall health after using Quell. Quell is available through select healthcare professionals and retailers.

'We are proud to have Quell recognized by APMA,' said Shai Gozani, MD, PhD, President and CEO NeuroMetrix. 'We know that the APMA sets a high standard for products that earn its Seal of Approval and are honored by their recognition of Quell as a 100% drug free option that is FDA cleared for day and night use for people with chronic pain. Quell was designed to meet the needs of people with various forms of chronic pain such as foot and leg pain, nerve pain, fibromyalgia pain, back pain and arthritic pain.'

NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

APMA

The American Podiatric Medical Association (APMA) is the nation's leading professional organization for today's podiatrists. Doctors of Podiatric Medicine (DPMs) are qualified by their education, training, and experience to diagnose and treat conditions affecting the foot, ankle, and structures of the leg. APMA has 53 state component locations across the United States and its territories, with a membership of more than 12,000 podiatrists. All practicing APMA members are licensed by the state in which they practice podiatric medicine. For more information, visit www.apma.org.

View source version on businesswire.com : http://www.businesswire.com/news/home/20151111006231/en/

NeuroMetrix, Inc. Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media

distributed by